Global Orthobiologics Market Professional Survey Report 2019
Orthobiologics are substances that orthopaedic surgeons use to help injuries heal more quickly. They are used to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in your body.
The rising geriatric population can be considered as a beneficial prospect. Increasing geriatric population offers surplus opportunities for the manufactures of orthobiologics. The major root of amputations are diseases related to ageing as osteoarthritis, musculoskeletal diseases, spine deformity, etc. Increase incidence of accidents owing to increasing urbanization is also a major factor expected to create numerous opportunities for orthobiologics manufacturers. Elevating surgical procedures also presents growth opportunities for the market. The increased incidences of trauma cases, lifestyle related diseases and other chronic disorders have led to rise in number of orthopaedic surgeries at a global level. This growing trend is anticipated to increase the sales of orthobiologics products in present and forthcoming years.
The global Orthobiologics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Orthobiologics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Orthobiologics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Orthobiologics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Orthobiologics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Medtronic
NuVasive
Stryker
Zimmer
Orthofix
Anika Therapeutics
DePuy Synthes (Johnson & Johnson)
Bioventus
Arthrex
SeaSpine
Sanofi-Aventis (Sanofi)
Djo Global
Seikagaku
RTI Surgical
Heraeus
Fidia Pharma
TRB
Allosource
Musculoskeletal Transplant Foundation
Ito
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Bone Growth Stimulators (BGS)
Viscosupplements
Bone Graft Substitute
Segment by Application
Hospitals
Ambulatory Surgical Centres
Orthopaedics Clinics
The rising geriatric population can be considered as a beneficial prospect. Increasing geriatric population offers surplus opportunities for the manufactures of orthobiologics. The major root of amputations are diseases related to ageing as osteoarthritis, musculoskeletal diseases, spine deformity, etc. Increase incidence of accidents owing to increasing urbanization is also a major factor expected to create numerous opportunities for orthobiologics manufacturers. Elevating surgical procedures also presents growth opportunities for the market. The increased incidences of trauma cases, lifestyle related diseases and other chronic disorders have led to rise in number of orthopaedic surgeries at a global level. This growing trend is anticipated to increase the sales of orthobiologics products in present and forthcoming years.
The global Orthobiologics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Orthobiologics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Orthobiologics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Orthobiologics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Orthobiologics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Medtronic
NuVasive
Stryker
Zimmer
Orthofix
Anika Therapeutics
DePuy Synthes (Johnson & Johnson)
Bioventus
Arthrex
SeaSpine
Sanofi-Aventis (Sanofi)
Djo Global
Seikagaku
RTI Surgical
Heraeus
Fidia Pharma
TRB
Allosource
Musculoskeletal Transplant Foundation
Ito
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Bone Growth Stimulators (BGS)
Viscosupplements
Bone Graft Substitute
Segment by Application
Hospitals
Ambulatory Surgical Centres
Orthopaedics Clinics
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
